Brief: Index Pharmaceuticals Q3 Operating Loss Narrows To SEK 7.7 Mln
Nov 25 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* Q3 NET SALES AMOUNTED TO SEK 0.0 (0.0) MILLION
* Q3 OPERATING LOSS AMOUNTED TO SEK -7.7 (-27.2) MILLION
Source text for Eikon: ID:nWkr511zQp
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen